Literature DB >> 8539336

Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat.

B J Cole1, M Hillmann, D Seidelmann, M Klewer, G H Jones.   

Abstract

The present series of experiments examined the effects of five benzodiazepine receptor (BZR) partial inverse agonists on the behaviour of rats on an elevated plus maze. The drugs were tested in a standard plus maze with 3-cm walls added to the open arms, as this has been shown to increase the sensitivity of the plus maze to anxiogenic-like drugs effects (Jones and Cole 1995). The drugs tested were FG 7142 (0-100 mg/kg), beta-CCE (0-30 mg/kg), ZK 132,556 (0-100 mg/kg), ZK 90 886 (0-30 mg/kg) and Ro 15-4513 (0-30 mg/kg). In addition, to allow a comparison with previous studies, the effects of three reference substances, DMCM (0-2.5 mg/kg), pentylenetetrazol (PTZ; 0-30 mg/kg) and yohimbine (0-5 mg/kg), were also examined. These three reference compounds produced a dose-dependent reduction in the duration of open arm exploration and the total number of open arm entries, indicative of anxiogenic-like effects. DMCM produced significant effects at the doses of 1.25 and 2.5 mg/kg, PTZ at 30 mg/kg, and yohimbine at 5 mg/kg. The BZR partial inverse agonist FG 7142 (10, 30 and 100 mg/kg) also reduced the duration of open arm exploration and the total number of arm entries. The minimally effective dose resulted in a receptor occupancy of approximately 80%. Ro 15-4513 also produced anxiogenic-like effects, but only at a dose (30 mg/kg) that resulted in a receptor occupancy of approximately 95%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539336     DOI: 10.1007/bf02245598

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

Review 1.  Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety.

Authors:  D E Redmond; Y H Huang
Journal:  Life Sci       Date:  1979-12-24       Impact factor: 5.037

2.  Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

Authors:  J M Stutzmann; B Eon; F Darche; M Lucas; J Rataud; O Piot; J C Blanchard; P M Laduron
Journal:  Neurosci Lett       Date:  1991-07-08       Impact factor: 3.046

3.  Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.

Authors:  G Puia; S Vicini; P H Seeburg; E Costa
Journal:  Mol Pharmacol       Date:  1991-06       Impact factor: 4.436

4.  The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CGS 8216.

Authors:  S E File; S Pellow
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-10

5.  Punishment of schedule-controlled behavior with beta-carboline injections: antagonism and comparisons with other compounds.

Authors:  K Takada; J E Barrett; M S Allen; J M Cook; J L Katz
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

6.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

7.  beta-Carboline and pentylenetetrazol effects on conflict behavior in the rat.

Authors:  T J Hill; D J Fontana; T C McCloskey; R L Commissaris
Journal:  Pharmacol Biochem Behav       Date:  1992-08       Impact factor: 3.533

8.  Interactions between the benzodiazepine receptor antagonist Ro 15-1788 (flumazepil) and the inverse agonist beta-CCE: behavioral studies with squirrel monkeys.

Authors:  J E Barrett; L S Brady; J M Witkin; J M Cook; P Larscheid
Journal:  Life Sci       Date:  1985-04-08       Impact factor: 5.037

9.  Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

Authors:  S Pellow; A L Johnston; S E File
Journal:  J Pharm Pharmacol       Date:  1987-11       Impact factor: 3.765

10.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

Authors:  S Pellow; S E File
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

View more
  20 in total

1.  Effect of clozapine on locomotor activity and anxiety-related behavior in the neonatal mice administered MK-801.

Authors:  Neslihan Pınar; Kubra Akillioglu; Fatih Sefil; Harun Alp; Mustafa Sagir; Ahmet Acet
Journal:  Bosn J Basic Med Sci       Date:  2015-08-11       Impact factor: 3.363

2.  Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors.

Authors:  John R Atack; Peter H Hutson; Neil Collinson; George Marshall; Graham Bentley; Christopher Moyes; Susan M Cook; Ian Collins; Keith Wafford; Ruth M McKernan; Gerard R Dawson
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Noradrenergic alpha-2 receptor modulators in the ventral bed nucleus of the stria terminalis: effects on anxiety behavior in postpartum and virgin female rats.

Authors:  Carl D Smith; Christopher C Piasecki; Marcus Weera; Joshua Olszewicz; Joseph S Lonstein
Journal:  Behav Neurosci       Date:  2013-06-24       Impact factor: 1.912

4.  Yohimbine anxiogenesis in the elevated plus maze is disrupted by bilaterally disconnecting the bed nucleus of the stria terminalis from the central nucleus of the amygdala.

Authors:  L Cai; H Bakalli; L Rinaman
Journal:  Neuroscience       Date:  2012-08-11       Impact factor: 3.590

5.  Use of the light-dark box to compare the anxiety-related behavior of virgin and postpartum female rats.

Authors:  Stephanie M Miller; Christopher C Piasecki; Joseph S Lonstein
Journal:  Pharmacol Biochem Behav       Date:  2011-08-07       Impact factor: 3.533

6.  Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.

Authors:  K S Sink; K N Segovia; J Sink; P A Randall; L E Collins; M Correa; E J Markus; V K Vemuri; A Makriyannis; J D Salamone
Journal:  Eur Neuropsychopharmacol       Date:  2009-12-16       Impact factor: 4.600

7.  Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats.

Authors:  Paola Morales; Nicola Simola; Diego Bustamante; Francisco Lisboa; Jenny Fiedler; Peter J Gebicke-Haerter; Micaela Morelli; R Andrew Tasker; Mario Herrera-Marschitz
Journal:  Exp Brain Res       Date:  2009-12-11       Impact factor: 1.972

8.  Effects of anxiogenic drugs on the emission of 22- and 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Maria Willadsen; Laura M Best; Markus Wöhr; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

9.  Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.

Authors:  Christopher L Kliethermes; Deborah A Finn; John C Crabbe
Journal:  Psychopharmacology (Berl)       Date:  2003-05-29       Impact factor: 4.530

10.  Effects of repeated yohimbine administration on reinstatement of palatable food seeking: involvement of dopamine D1 -like receptors and food-associated cues.

Authors:  Kevin T Ball; Leah Miller; Christopher Sullivan; Ashleigh Wells; Olivia Best; Brittany Cavanaugh; Taylor Copus; Nathan Corrigan; Shaina Hawkins; Krista Kobbe; Ashley Schoener; Johnathan Steiger; Lauren Vieweg
Journal:  Addict Biol       Date:  2015-07-29       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.